Oncogene - Table of Contents alert Volume 35 Issue 10

If you are unable to see the message below, click here to view.

Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions TABLE OF CONTENTS Volume 35, Issue 10 (March 2016) In this issue Reviews Original Articles Short Communications Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis Focus Collection: Cancer & Metabolism While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells. Explore the Special Issue in full.  Reviews Top Tumor progression and the different faces of the PERK kinase D Pytel, I Majsterek and J A Diehl Oncogene 2016 35: 1207-1215; advance online publication, June 1, 2015; 10.1038/onc.2015.178 Abstract | Full Text The biology of circulating tumor cells K Pantel and M R Speicher Oncogene 2016 35: 1216-1224; advance online publication, June 8, 2015; 10.1038/onc.2015.192 Abstract | Full Text Original Articles Top Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells I V Fedorenko, E V Abel, J M Koomen, B Fang, E R Wood, Y A Chen, K J Fisher, S Iyengar, K B Dahlman, J A Wargo, K T Flaherty, J A Sosman, V K Sondak, J L Messina, G T Gibney and K S M Smalley Oncogene 2016 35: 1225-1235; advance online publication, June 15, 2015; 10.1038/onc.2015.188 Abstract | Full Text IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2 S Hubackova, A Kucerova, G Michlits, L Kyjacova, M Reinis, O Korolov, J Bartek and Z Hodny Oncogene 2016 35: 1236-1249; advance online publication, May 18, 2015; 10.1038/onc.2015.162 Abstract | Full Text Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP S J H Ricoult, J L Yecies, I Ben-Sahra and B D Manning Oncogene 2016 35: 1250-1260; advance online publication, June 1, 2015; 10.1038/onc.2015.179 Abstract | Full Text Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity L O'Leary, A M van der Sloot, C R Reis, S Deegan, A E Ryan, S P S Dhami, L S Murillo, R H Cool, P Correa de Sampaio, K Thompson, G Murphy, W J Quax, L Serrano, A Samali and E Szegezdi Oncogene 2016 35: 1261-1270; advance online publication, June 8, 2015; 10.1038/onc.2015.180 Abstract | Full Text Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition K Zhang, H Zhao, Z Ji, C Zhang, P Zhou, L Wang, Q Chen, J Wang, P Zhang, Z Chen, H H Zhu and W-Q Gao Oncogene 2016 35: 1271-1282; advance online publication, June 8, 2015; 10.1038/onc.2015.184 Abstract | Full Text Activating ERBB4 mutations in non-small cell lung cancer K J Kurppa, K Denessiouk, M S Johnson and K Elenius Oncogene 2016 35: 1283-1291; advance online publication, June 8, 2015; 10.1038/onc.2015.185 Abstract | Full Text MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B OPEN S-J Park, J W Shim, H S Park, D-Y Eum, M-T Park, J Mi Yi, S H Choi, S D Kim, T G Son, W Lu, N D Kim, K Yang and K Heo Oncogene 2016 35: 1292-1301; advance online publication, June 1, 2015; 10.1038/onc.2015.187 Abstract | Full Text Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer J Niu, A Xue, Y Chi, J Xue, W Wang, Z Zhao, M Fan, C H Yang, Z-M Shao, L M Pfeffer, J Wu and Z-H Wu Oncogene 2016 35: 1302-1313; advance online publication, June 1, 2015; 10.1038/onc.2015.189 Abstract | Full Text The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation C-C Chen, K-H Kim and L F Lau Oncogene 2016 35: 1314-1323; advance online publication, June 1, 2015; 10.1038/onc.2015.190 Abstract | Full Text Short Communications Top Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations L Golmard, C Delnatte, A Laugé, V Moncoutier, C Lefol, K Abidallah, H Tenreiro, F Copigny, M Giraudeau, C Guy, C Barbaroux, G Amorim, A Briaux, V Guibert, J Tarabeux, S Caputo, A Collet, P Gesta, O Ingster, M-H Stern, E Rouleau, A de Pauw, M Gauthier-Villars, B Buecher, S Bézieau, D Stoppa-Lyonnet and C Houdayer Oncogene 2016 35: 1324-1327; advance online publication, June 1, 2015; 10.1038/onc.2015.181 Abstract | Full Text Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF J Cisowski, V I Sayin, M Liu, C Karlsson and M O Bergo Oncogene 2016 35: 1328-1333; advance online publication, June 1, 2015; 10.1038/onc.2015.186 Abstract | Full Text Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells J Kim, Y Liu, M Qiu and Y Xu Oncogene 2016 35: 1334-1340; advance online publication, June 15, 2015; 10.1038/onc.2015.205 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.